Zydus, MSN launch first generic Adempas in US
Zydus Lifesciences and MSN Laboratories have launched the first generic version of Bayer's Adempas (riociguat tablets) in the US, after receiving USFDA approval. The tablets are available in all five strengths: 0.5…
